Association between the SUA/Scr ratio and carotid plaque in patients with ischemic stroke based on gender and age: a retrospective study

  • 0Department of Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.

|

|

Summary

This summary is machine-generated.

The serum uric acid/serum creatinine (SUA/Scr) ratio is linked to carotid plaques (CAPs) in ischemic stroke patients. This association is particularly notable in young and middle-aged men.

Area Of Science

  • Neurology
  • Nephrology
  • Cardiovascular Medicine

Background

  • Ischemic stroke is a leading cause of disability and mortality worldwide.
  • Carotid plaques (CAPs) are a significant risk factor for ischemic stroke.
  • Biomarkers that can predict the presence of CAPs are crucial for stroke prevention strategies.

Purpose Of The Study

  • To investigate the association between the serum uric acid/serum creatinine (SUA/Scr) ratio and the presence of carotid plaques (CAPs) in patients who have experienced an ischemic stroke.
  • To determine if the SUA/Scr ratio can serve as a predictive marker for CAPs in this patient population.

Main Methods

  • A cohort of 12,072 ischemic stroke patients was analyzed.
  • Patients were stratified into three groups based on SUA/Scr tertiles.
  • Logistic regression and ROC curve analysis were employed to assess the association and predictive value of the SUA/Scr ratio for CAPs.

Main Results

  • A significant association was found between the SUA/Scr ratio and CAPs (OR: 1.060; 95% CI: 1.024-1.098).
  • Patients in the highest SUA/Scr tertile (Q3) had a higher likelihood of developing CAPs compared to the lowest tertile (Q1) (OR: 1.175; 95% CI: 1.043-1.324).
  • This association was prominent in young and middle-aged men (<60 years) but not observed in women or older patients (≥60 years).

Conclusions

  • The SUA/Scr ratio is significantly associated with the presence of carotid plaques in ischemic stroke patients.
  • The SUA/Scr ratio may serve as a potential biomarker for identifying patients at higher risk of CAPs, particularly among younger and middle-aged men.
  • Further research is warranted to elucidate the underlying mechanisms and clinical implications of this association.